Can ureteral stents be omitted from radical cystectomy with continent diversion? An ACS-NSQIP analysis of the early postoperative outcomes
World Journal of Urology · 2025
DOI: 10.1007/s00345-025-05685-3 ↗Kurz gefasst
Fachartikel in der Zeitschrift World Journal of Urology, 2025. Verfasst von Yara Ghandour und 5 weiteren Autor:innen. Beteiligte Einrichtung: Division of Urology, Department of Surgery, American University of Beirut Medical Center, Riad El-Solh, Beirut, 1107 2020, Lebanon. Hauptthemen laut MEDLINE: Cystectomy, Stents, Urinary Bladder Neoplasms, Ureter. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 25 Literaturangaben.
Abstract (Originalsprache)
PURPOSE: Radical cystectomy with continent diversion is the standard treatment for muscle-invasive bladder cancer. Evidence supporting the necessity of ureteral stent use after this procedure is limited. This study compares 30-day postoperative outcomes of radical cystectomy with continent diversion using neobladder reconstruction in patients managed with and without ureteral stents. METHODS: A retrospective cohort study using the 2019-2022 ACS-NSQIP database included 1,318 patients who underwent radical cystectomy with continent diversion using neobladder reconstruction. We compared baseline characteristics and perioperative factors between the stented (n = 1,216) and stentless group (n = 102). Univariate and multivariate analyses assessed the relationship between stent use and perioperative outcomes, as well as 1:1 propensity score matching. RESULTS: Patient demographics and comorbidities were comparable between the two groups. Similarly, preoperative and intraoperative factors showed no significant differences, except for a higher drain placement rate in the stented group (98.6% vs. 89.2%, p < 0.001). Postoperatively, the stented cohort exhibited higher odds of minor complications (CD grade 1-2; OR 1.66, p = 0.018), and an increased incidence of progressive renal insufficiency (8.7% vs. 1.3%, p = 0.024) and bleeding requiring transfusion (29.8% vs. 19.6%, p = 0.030). Ureteral obstruction, urinary leak, anastomotic leak rates, hospital stay, and readmission and reoperation rates remained similar between the two groups. Propensity score matching (1:1) for patients with and without stents supported the results of the multivariate logistic regression. CONCLUSION: Stent omission after radical cystectomy with continent diversion using neobladder reconstruction was not associated with significant differences in major complications, ureteral obstruction, readmission, or reoperation rates. It is potentially a safe alternative associated with fewer minor complications.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Urology, Department of Surgery, American University of Beirut Medical Center, Riad El-Solh, Beirut, 1107 2020, Lebanon.
- Division of Urology, Department of Surgery, American University of Beirut Medical Center, Riad El-Solh, Beirut, 1107 2020, Lebanon. ae67@aub.edu.lb.
ORCID-Profile: Yara Ghandour, Baraa AlJardali, Towfik Sebai, Marwan Zein, Jad Najdi, Albert El Hajj
Zitieren
APA
Ghandour, Y., AlJardali, B., Sebai, T., Zein, M., Najdi, J., & Hajj, A. E. (2025). Can ureteral stents be omitted from radical cystectomy with continent diversion? An ACS-NSQIP analysis of the early postoperative outcomes. World Journal of Urology. https://doi.org/10.1007/s00345-025-05685-3
Vancouver
Ghandour Y, AlJardali B, Sebai T, Zein M, Najdi J, Hajj AE. Can ureteral stents be omitted from radical cystectomy with continent diversion? An ACS-NSQIP analysis of the early postoperative outcomes. World Journal of Urology. 2025. doi:10.1007/s00345-025-05685-3
BibTeX
@article{Ghandour2025,
author = {Ghandour, Yara and AlJardali, Baraa and Sebai, Towfik and Zein, Marwan and Najdi, Jad and Hajj, Albert El},
title = {Can ureteral stents be omitted from radical cystectomy with continent diversion? An ACS-NSQIP analysis of the early postoperative outcomes},
journal = {World Journal of Urology},
year = {2025},
doi = {10.1007/s00345-025-05685-3}
}
EUVIMED